Local Institution - 001-108 — New Haven, Connecticut

Local Institution - 001-108 is a clinical research site located in New Haven, Connecticut, United States 06520.

Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 001-108 has participated in 1 clinical trials.

Therapeutic areas: Solid Tumor, Advanced Solid Tumor, Non Small Cell Lung Cancer.

Sponsors: Mirati Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 001-108?

Local Institution - 001-108 has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 001-108 conducted?

Local Institution - 001-108 has 1 clinical trials on record. Their work covers Solid Tumor, Advanced Solid Tumor, Non Small Cell Lung Cancer.

Is Local Institution - 001-108 accredited by Crixeo Health?

Local Institution - 001-108 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 001-108?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.